Skip to content

Resilience Intervention for Older, HIV-Infected Women

Developing a Resilience Intervention for Older, HIV-Infected Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03071887
Acronym
BRIgHT
Enrollment
13
Registered
2017-03-07
Start date
2017-11-27
Completion date
2018-08-27
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resilience, Psychological

Brief summary

The goal of this study is to refine and pilot the Relaxation Response Resiliency (3RP) intervention for women age 50 and over who are living with HIV, a group especially burdened by stressors related both to aging and living with chronic disease. The investigators will adapt the 3RP resiliency intervention to the needs of this population and conduct preliminary testing of the group intervention via an open pilot study.

Detailed description

Overview. Participants will be women living with HIV (N=up to 40) age 50 or over. Women will be recruited from the Boston area. Based on the investigators' qualitative work, the investigators will deliver an adapted version of the 3RP resiliency intervention to groups of 5-8 HIV-infected women age 50 and over. The 3RP intervention will consist of 8-10 weekly sessions of 90 minutes each focused on skills training to build and enhance resilience. The investigators will conduct baseline and post-treatment quantitative assessments, in addition to individual exit interviews to solicit feedback on the intervention. These data will be used to inform the design of a future randomized pilot study. Study procedures. Participants (N = up to 40) will be HIV-infected women age 50 or over . Participants will be recruited via study flyers (posted in the infectious disease clinics at local hospitals and in the waiting areas of Boston area community organizations) and provider referral. Once an individual expresses interest in the study, a research assistant will screen that individual to assess study eligibility criteria. Individuals who meet inclusion criteria will be invited to sign informed consent and complete an in-person baseline assessment. Participants will then complete the intervention (described below), a post-treatment assessment, and an individual in-depth exit interview to provide feedback on their experience in the study. 3RP Intervention: Once enrolled in the study, participants will complete weekly group sessions of the 3RP intervention. Sessions will focus on developing an understanding of stress sources and physiology, and on developing a regular practice of eliciting the relaxation response (RR) and learning cognitive behavioral and positive psychology skills to enhance resiliency to long-term stress. Participants will be encouraged to practice skills (RR practice, thoughts records to learn adaptive thinking) between group sessions.

Interventions

The 3RP blends stress management principles, cognitive behavioral therapy, and positive psychology. The 3RP focuses on 3 major areas: (1) eliciting the relaxation response; (2) increasing stress awareness; and (3) promoting adaptive strategies. The 3RP intervention currently consists of eight, 90-minute weekly group sessions. The investigators plan to adapt the intervention to address common concerns for older, HIV-infected women, including: stress of managing a chronic long-term, life threatening illness; additional medical comorbidities; pain and fatigue; stigma and social isolation; depression and anxiety; and sexuality concerns.

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

This is an open pilot of the adapted Relaxation Response Resiliency Program (3RP).

Eligibility

Sex/Gender
FEMALE
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* biologically born women who endorse a female identity * HIV-infected * age 50 or older * English speaking

Exclusion criteria

* presence of an active (i.e. untreated) and interfering psychiatric disorder (e.g., bipolar disorder, schizophrenia, substance abuse) * have participated in a structured cognitive behavioral therapy and/or a mind-body intervention in the past year

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Completing Treatment SessionsApproximately 10 weeks after baselineThe investigators will assess feasibility by collecting data on the number of completed treatment sessions.
Participant Satisfaction With Study ProceduresApproximately 10 weeks after baselineAcceptability will be assessed using scores on the Client Satisfaction Questionnaire (CSQ-8). Response options as follows, Very satisfied, Mostly satisfied, Indifferent or mildly dissatisfied, and Quite dissatisfied.

Countries

United States

Participant flow

Recruitment details

The three open pilot groups and qualitative exit interviews were conducted between December 2017 and July 2018 through community outreach, flyers, and referrals from healthcare providers at the Infectious Disease units of two Boston-area hospitals.

Participants by arm

ArmCount
Treatment: Relaxation Response Resiliency Program (3RP)
The 3RP blends stress management principles, cognitive behavioral therapy, and positive psychology. The 3RP focuses on 3 major areas: (1) eliciting the relaxation response; (2) increasing stress awareness; and (3) promoting adaptive strategies. The 3RP intervention currently consists of eight, 90-minute weekly group sessions. The investigators adapted the intervention to address common concerns for older, HIV-infected women, including: stress of managing a chronic long-term, life threatening illness; additional medical comorbidities; pain and fatigue; stigma and social isolation; depression and anxiety; and sexuality concerns.
13
Total13

Baseline characteristics

CharacteristicTreatment: Relaxation Response Resiliency Program (3RP)
Age, Continuous57.6 years
STANDARD_DEVIATION 5.2
Current Employment Status
Disabled/retired
9 Participants
Current Employment Status
Full-Time
1 Participants
Current Employment Status
Other
1 Participants
Current Employment Status
Part-Time
2 Participants
Education
College/graduate school partial/degree
7 Participants
Education
High school graduate/GED
1 Participants
Education
Less than high school degree
5 Participants
Monthly Income
$10,000 or less
9 Participants
Monthly Income
More than $10,000
4 Participants
Race/Ethnicity, Customized
Black/African American
8 Participants
Race/Ethnicity, Customized
Other
1 Participants
Race/Ethnicity, Customized
White
4 Participants
Relationship Status
Married/Partnered
3 Participants
Relationship Status
Separated/Divorced
5 Participants
Relationship Status
Single
5 Participants
Sex: Female, Male
Female
13 Participants
Sex: Female, Male
Male
0 Participants
Years since diagnosis
Less than 5 years ago
1 Participants
Years since diagnosis
More than 5 years ago
12 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 13
other
Total, other adverse events
0 / 13
serious
Total, serious adverse events
0 / 13

Outcome results

Primary

Number of Participants Completing Treatment Sessions

The investigators will assess feasibility by collecting data on the number of completed treatment sessions.

Time frame: Approximately 10 weeks after baseline

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Treatment: Relaxation Response Resiliency Program (3RP)Number of Participants Completing Treatment SessionsAttended at least half of group sessions4 Participants
Treatment: Relaxation Response Resiliency Program (3RP)Number of Participants Completing Treatment SessionsAttended fewer than half of group sessions9 Participants
Primary

Participant Satisfaction With Study Procedures

Acceptability will be assessed using scores on the Client Satisfaction Questionnaire (CSQ-8). Response options as follows, Very satisfied, Mostly satisfied, Indifferent or mildly dissatisfied, and Quite dissatisfied.

Time frame: Approximately 10 weeks after baseline

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Treatment: Relaxation Response Resiliency Program (3RP)Participant Satisfaction With Study ProceduresVery satisfied6 Participants
Treatment: Relaxation Response Resiliency Program (3RP)Participant Satisfaction With Study ProceduresMostly satisfied1 Participants

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026